Taken together, the surface expressions of TNFSF13B receptors were upregulated on human myeloma cells, promoting myeloma cell proliferation and survival via TNFSF13B signal transduction through the canonical NF-κB pathway. The gene discussed is NFKB1; the disease is plasma cell myeloma.